Integral Ad Science surveyed digital ad professionals to learn how the challenges they face will drive change in the digital advertising industry.
The 4A’s filed comments in December on proposed regulations by the Centers for Medicare & Medicaid (CMS) that would require all TV advertisements featuring prescription drugs and biological products to include the list price.
WARC highlights key marketing trends for 2019.
The 4A’s, working via its Board membership in the Digital Advertising Alliance (DAA), help drive a self-regulatory solution to increase transparency in political advertising.
The 4A’s is innovating its approach to conferences, focusing on events that address urgent issues with tangible actions, drilling-down on industry challenges to better meet the realities and needs of its members in real time. To mark the shift towards action-oriented events, the 4A’s will forgo hosting its industry-wide spring conference in 2019, and will instead host an inaugural Decisions 20/20 forum, on March 25-26, 2019 in Washington D.C. In addition, due to its popularity, the 4A’s will expand its annual Management Practitioners’ Forum (MPF) to become a standalone event, taking place on April 29-30, 2019 at the W Downtown in Chicago.
PubMatic provides insights for media buyers and publishers on how to successfully operate in the new programmatic environment. This paper focuses on fraud prevention and practices that encompass inventory quality control.
Read this white paper from R3 Worldwide to get a better handle on programmatic media buying transparency.
In his keynote, P&G Chief Brand Officer, Marc Pritchard, explores the possible causes of why it’s been so tough between marketers and agencies.
In this Member Bulletin, 4A’s President and CEO Nancy Hill outlines two new initiatives related to the issue of media transparency.